Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1
- 20 April 2024
- journal article
- research article
- Published by Elsevier in Molecular and Cellular Endocrinology
- Vol. 589, 112252
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 59 references indexed in Scilit:
- miR-455-5p promotes pathological cardiac remodeling via suppression of PRMT1-mediated Notch signaling pathwayCellular and Molecular Life Sciences, 2023
- Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3aCellular and Molecular Life Sciences, 2023
- Crafting a Blueprint for MicroRNA in Cardiovascular Diseases (CVDs)Current Problems in Cardiology, 2023
- MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4BActa Pharmaceutica Sinica B, 2021
- LncRNA-NEAT1 promotes proliferation of T-ALL cells via miR-146b-5p/NOTCH1 signaling pathwayPathology - Research and Practice, 2020
- Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regenerationBasic Research in Cardiology, 2020
- Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsArchives of Toxicology, 2015
- Autophagy: Renovation of Cells and TissuesCell, 2011
- Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptidesJournal of Molecular Medicine, 2011
- Autophagy: cellular and molecular mechanismsThe Journal of Pathology, 2010